Thera Tablets with Beta Carotene Recalled for Missing Labeling Information
The Harvard Drug Group is recalling Thera Tablets with Beta Carotene because some blister cards are missing product information on the back.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates a remote possibility of adverse health consequences. The issue is a packaging and labeling defect where information is missing from the back of the blister card, which falls under the 'packaging-only problems' criterion for a Low severity score.
Plain-English summary
The Harvard Drug Group, LLC is recalling 5,700 unit doses of Thera Tablets with Beta Carotene Dietary Supplement. The recall involves 10 x 10 cartons with Lot Number M-00953 and an expiration date of 06-2015.
The recall was initiated after the firm received a complaint on December 16, 2014, stating that blister packets were missing labeling information. An investigation confirmed that six 2 x 5 blister cards inside a carton were missing some or all of the product information on the back of the blister card.
The affected products were distributed domestically in Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Kentucky, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, Nebraska, New Jersey, New York, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, and West Virginia. Consumers should check their products for the specific lot number and expiration date and contact the firm for instructions if they possess the affected items.
The recalled product
- Product
- Thera Tablets with Beta Carotene Dietary Supplement
- Manufacturer
- The Harvard Drug Group, LLC
- Category
- Food — Dietary Supplement
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot Number: M-00953 Expiration Date: 06-2015
- UPC Code: 3 09040 53961 8
Distribution
Related recalls
Same manufacturer · The Harvard Drug Group, LLC
See all →- ModerateMETHYLERGONOVINE MALEATE Tablets 0.2 mg Drug Recall
FDA (Drugs) · 2026-07-01
- ModerateOmega-3-Acid Ethyl Esters capsules recalled for failed capsule specifications
FDA (Drugs) · 2026-04-29
- HighMajor Pharmaceuticals memantine extended-release capsules fail dissolution specifications
FDA (Drugs) · 2026-04-22
- ModerateMidodrine hydrochloride tablets recalled over inadequately sealed blister packaging
FDA (Drugs) · 2026-03-11
- ModerateGabapentin blister packs recalled after unknown impurity exceeded specification
FDA (Drugs) · 2025-10-29
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02